Evidence map›Paper›PMID 30142748›Full record

ArticleIEEE transactions on bio-medical engineering2019

Adaptive Zone Model Predictive Control of Artificial Pancreas Based on Glucose- and Velocity-Dependent Control Penalties.

Dawei Shi, Eyal Dassau, Francis J Doyle

Abstract read
In one paragraph

Article in IEEE transactions on bio-medical engineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 88 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Recent advances in the precision control strategy of artificial pancreas.Medical & biological engineering & computing · 2024
    Review
  7. Article
  8. Review
  9. Glucose Rate-of-Change and Insulin-on-Board Jointly Weighted Zone Model Predictive Control.IEEE transactions on control systems technology : a publication of the IEEE Control Systems Society · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dawei Shi
Eyal Dassau
Francis J Doyle
Harvard University · US

Funding

Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) TrialUC4DK108483 · NIDDK · UNIVERSITY OF VIRGINIA · PI ANDERSON, STACEY, DOYLE, FRANCIS J · 2016 to 2016
$12.7M
On-body ecosystem for automated insulin delivery in type 1 diabetesDP3DK113511 · NIDDK · YALE UNIVERSITY · PI DASSAU, EYAL, LAFFEL, LORI M · 2017 to 2017
$3.0M
Pediatric Artificial Pancreas System for Enhanced Diabetes Management in Young Children with Type 1 DiabetesDP3DK104057 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI DASSAU, EYAL, DOYLE, FRANCIS J · 2014 to 2014
$1.8M
NIDDK NIH HHS DP3 DK104057NIDDK NIH HHS DP3 DK113511NIDDK NIH HHS UC4 DK108483
6 · The paper itself

Abstract

objectiveZone model predictive control (MPC) has been proven to be an efficient approach to closed-loop insulin delivery in clinical studies. In this paper, we aim to safely reduce mean glucose levels by proposing control penalty adaptation in the cost function of zone MPC.

methodsA zone MPC method with a dynamic cost function that updates its control penalty parameters in real time according to the predicted glucose and its rate of change is developed. The proposed method is evaluated on the entire 100-adult cohort of the FDA-accepted UVA/Padova T1DM simulator and compared with the zone MPC tested in an extended outpatient study.

resultsFor unannounced meals, the proposed method leads to statistically significant improvements in terms of mean glucose (153.8 mg/dL vs. 159.0 mg/dL; ) and percentage time in [70, 180] mg/dL ([Formula: see text] vs. [Formula: see text]; ) without increasing the risk of hypoglycemia. Performance for announced meals is similar to that obtained without adaptation. The proposed method also behaves properly and safely for scenarios of moderate meal-bolus and basal rate mismatches, as well as simulated unannounced exercise. Advisory-mode analysis based on clinical data indicates that the method can reduce glucose levels through suggesting additional safe amounts of insulin on top of those suggested by the zone MPC used in the study.

conclusionThe proposed method leads to improved glucose control without increasing hypoglycemia risks. SIGNIFICANCE: The results validate the feasibility of improving glucose regulation through glucose- and velocity-dependent control penalty adaptation in MPC design.

Indexed as

Blood GlucoseInsulin Infusion SystemsModels, StatisticalPancreas, ArtificialAdultAlgorithmsComputer SimulationDiabetes Mellitus, Type 1HumansInsulinMealsBlood GlucoseInsulin

Identifiers

PMID30142748
PMCPMC6760658
OpenAlexW2922599863

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.